Glutathione peroxidase-3 (Gpx3), the extracellular glutathione peroxidase synthesized largely in the kidney, binds to basement membranes of renal cortical epithelial cells. The present study assessed extra-renal expression of Gpx3 using RT-PCR and presence of Gpx3 protein using immunocytochemistry. Gpx3 expression was higher in kidney and epididymis than in other tissues. Gpx3 bound to basement membranes of epithelial cells in the gastrointestinal tract, the efferent ducts connecting the seminiferous tubules with the epididymis, the bronchi, and type II pneumocytes. It was not detected on the basement membrane of type I pneumocytes. Gpx3 was also present in the lumen of the epididymis. Transplantation of Gpx3 +/+ kidneys into Gpx3 -/-mice led to Gpx3 binding to the same basement membranes to which it bound in Gpx3 +/+ mice but not to its presence in the epididymal lumen. These results show that Gpx3 from the blood binds to basement membranes of specific epithelial cells and indicate that the cells modify their basement membranes to cause the binding. They further indicate that at least two Gpx3 compartments exist in the organism. In one compartment, kidney supplies Gpx3 through the blood to specific basement membranes in a number of tissues. In the other compartment, the epididymis provides Gpx3 to its own lumen. Tissues other than kidney and epididymis express Gpx3 at lower levels and may supply Gpx3 to other compartments.
Introduction
Glutathione peroxidase-3 (Gpx3) is an extracellular selenoprotein that accounts for nearly all the glutathione peroxidase activity in plasma (16) . The principal source of plasma Gpx3 is kidney proximal convoluted tubule (PCT) cells (2, 22, 23) , which are supplied with selenium by megalin-mediated endocytosis of selenoprotein P (Sepp1) from the glomerular filtrate (17).
Our group recently reported that Gpx3 binds in a specific manner to the basement membrane of renal cortical tubule cells (16) . Moreover, the amount of Gpx3 in the kidney was estimated to be greater than the amount circulating in the plasma. These findings indicate that a substantial amount of the enzyme is present in bound form and raise the possibility that such binding might occur in extra-renal tissues and play a role in the function of the enzyme.
To extend our observations, we have assessed the expression of Gpx3 by a number of tissues as well as the presence of Gpx3 protein in them. We have also assessed the ability of the kidney to provide Gpx3 to extra-renal tissues by transplanting Gpx3 +/+ kidneys into
Gpx3
-/-mice. Our results confirm that high expression of Gpx3 mRNA is limited to kidney and epididymis but show that Gpx3 localizes to specific basement membranes in many tissues. Moreover, Gpx3 produced by the kidney can populate those same extrarenal basement membranes but does not account for the Gpx3 in the lumen of the epididymis.
Methods

Animal husbandry
Separate Gpx3 -/-and Gpx3 +/+ colonies were established from mice that had been backcrossed 3 times with C57BL/6 mice (16) . The mice were fed pelleted Torula yeastbased diets (Harlan-Teklad, Madison, WI) deficient in selenium or supplemented with 0.25 mg selenium/kg as sodium selenite (8). Food and water were provided ad libitum.
The animal room light cycle was 14 h light and 10 h dark.
Mice used for immunocytochemical experiments were euthanized with CO 2 and tissues were removed and processed immediately. Mice used for other experiments were anesthetized with isoflurane and exsanguinated via the inferior vena cava using a syringe and needle. Blood was treated with disodium EDTA (1 mg/ml) to prevent clotting and plasma was separated by centrifugation at 16,000 g for 2 min. Tissues and plasma were stored at -80ºC until they were assayed for Gpx3 or selenium. Tissues used for RNA isolation, except for intestines, were frozen immediately in liquid nitrogen and stored at -80ºC. Intestines were rinsed with PBS. The intestine was then cut into duodenum (proximal 3 cm), jejunum (proximal half of remaining small intestine), and ileum (distal half of remaining small intestine) sections, and frozen in liquid nitrogen. The Vanderbilt University Institutional Animal Care and Use Committee approved all procedures.
Kidney transplantation
The kidney transplantation protocol has been published (15) and is outlined here.
After anesthesia had been established with isoflurane, the abdomen of the donor Gpx3 +/+ mouse was opened and the left kidney was exposed. The renal vein and artery were isolated and the ureter was dissected down to the bladder without stripping its fat and cut with a small (1-2 mm) bladder patch. After clamping the aorta above the renal artery, a 30-gauge needle was introduced into the aorta, the inferior vena cava was cut, and the graft was perfused with 1 mL of cold saline solution containing 100 µg heparin/mL.
After flushing and cooling it with saline at 4°C, the donor kidney was ready for transplant.
After anesthesia had been established in the recipient with isoflurane, the abdomen was opened and the donor Gpx3 +/+ kidney was positioned. The donor renal artery, renal vein, and ureter were connected to the aorta, inferior vena cava, and bladder, respectively, through end-to-side anastomoses. On completion of transplantation, the native left Gpx3 -/-kidney, renal artery, renal vein, and ureter were ligated and divided. The native left kidney was then removed. The abdominal wall was sutured and the skin was closed.
Thus in this procedure, one Gpx3 +/+ kidney was transplanted to replace one native Gpx3 -/-kidney which was removed, resulting in mice with one Gpx3 +/+ kidney and one Gpx3 -/-kidney. The mice with transplanted kidneys were allowed to recover in a cage placed on a warming blanket. They were monitored constantly until they were awake and able to right themselves. The diet fed to the transplanted mice was the selenium-supplemented diet. Tissues were removed for biochemical analysis and immunocytochemical study 14 days after the transplant.
A separate experimental protocol carried out at the same time as the present study verified that transplanted kidneys functioned well enough to support life. In that protocol, no results of which are presented here, a Gpx3 +/+ mouse received a Gpx3 -/-kidney and had one of its native kidneys removed. Two weeks later the other native kidney was removed, leaving the mouse with only the transplanted Gpx3 -/-kidney. Mice subjected to this protocol were followed for 6 more weeks. Thus, the transplanted kidney functioned well enough to support life for at least 6 weeks.
RT-PCR
Tissues were pulverized under liquid nitrogen and homogenized in Trizol Reagent (Invitrogen, Carlsbad, CA). RNA was isolated according to the manufacturer's protocol. StepOnePlus analysis software.
Selenium and glutathione peroxidase assays
Selenium was determined in whole tissues by the method of Koh and Benson (12) as modified by Sheehan and Gao (20) . Glutathione peroxidase activity was measured in plasma as previously described using 0.25 mM H 2 O 2 as substrate (13). Protein concentration was determined using bicinchoninic acid reagent (Pierce Chemical Co., Rockford, IL).
Western detection of Gpx3
Polyclonal antibody preparation #8096 (16) was used for western analyses and immunocytochemistry experiments. For the western blots used to assess Gpx3 in transplanted and native kidneys, SDS/PAGE was performed using 10% Bis-Tris NuPAGE Novex acrylamide gels (Invitrogen Inc., Carlsbad CA) as described previously (16) . The blots were imaged using an Odyssey infrared imager.
For the western blots used to quantify Gpx3, proteins were separated on SDS/PAGE gels made with 15% Protogel (National Diagnostics, Atlanta, GA) as described in a previous publication (16) . After transfer of the proteins to nitrocellulose, the blots were blocked with 3% BSA in 0.5 M NaCl, 20 mM Tris, 0.05% Tween 20, pH 7.0. Following sequential incubations with antibody preparation #8096 and horseradish peroxidaseconjugated goat anti-rabbit whole-molecule IgG, Gpx3 protein was detected using
Western Lighting ECL chemiluminescence reagent (Perkin-Elmer, Boston, MA). Gpx3 protein ECL signal density was quantified using ImageJ software program (NIH).
Immunofluorescence microscopy
Mouse tissues were fixed and stained as described in detail in a previous publication (16) . The primary antibody used for Gpx3 was #8096. Hoechst 33258 was used to stain DNA and Alexa 488-phalloidin (Invitrogen) was used to stain F-actin. Specimens were examined by phase contrast and epifluorescence microscopy. Digital images were made.
Each experiment was carried out with at least three mice and the images shown are representative of all replicates.
Results
Expression of Gpx3 mRNA by tissues
The highest concentration of Gpx3 mRNA has been reported to occur in the kidney (7, 9, 19). We re-assessed and quantified its presence in a number of tissues using RT-PCR. Figure 1 shows that kidney had the highest Gpx3 mRNA relative to hprt mRNA concentration of the tissues we studied. The concentration in the epididymis was 18% of that in kidney. Other tissues studied were all less than 6% of that in kidney, with testis, small intestine, brain, and liver less than 1%. Ct values of Gpx3 expression (not shown)
generally agreed with the relative values. Thus, high expression of Gpx3 mRNA was restricted to kidney and epididymis, but other tissues that we studied expressed it at lower levels.
Presence of Gpx3 protein in tissues
Gpx3 protein was present in a number of tissues, including some with low expression of its mRNA. 
Gpx3
-/-mice, did not stain for the enzyme (Fig 3B and not shown) , demonstrating the specificity of the antiserum used to detect Gpx3.
Evidence that the Gpx3 observed was attached to basement membrane was provided by an en face view of the basement membrane in duodenum (Fig 2C) that revealed characteristic pores (14). Additionally, staining of sequential sections of jejunum for collagen IV and Gpx3 demonstrated staining of the two proteins in the same position (not shown). Thus, we conclude that Gpx3 bound to certain basement membranes in the gastrointestinal tract as it had been shown to do in the kidney cortex (16) .
Not all basement membranes bound Gpx3. This is illustrated by Fig 2D of liver.
Gpx3 was present in the basement membrane of the bile duct but not in blood vessel endothelial cell basement membranes.
In the lung, basement membranes of the bronchioles and type II pneumocytes bound Gpx3 (Fig 4A) . The type I pneumocyte basement membrane did not bind Gpx3 even though it is continuous with the basement membrane of type II pneumocytes.
Gpx3 was present in the male reproductive tract. Figure 5A shows that Gpx3 bound to basement membranes in the efferent ducts that connect the seminiferous tubules with the epididymis but did not bind to epithelial cell basement membranes in the epididymis (Figs 5A, 6A, and 6C).
Gpx3 was present between the nucleus and the apical plasma membrane of epithelial cells in the distal epididymal caput (Fig 6A) and in the cauda (Fig 6C) . It was also detected in the epididymal lumen (Figs 6A and 6C), suggesting that the epithelial cells of the epididymis secrete Gpx3 apically into the lumen.
Several other tissues were stained to determine whether Gpx3 was present in them.
No Gpx3 was detected in brain, heart, skeletal muscle, thymus, skin, or spleen ( Table 1) .
Source of basement membrane-bound Gpx3
Because kidney is the major source of plasma Gpx3, we carried out experiments to determine whether that organ can supply Gpx3 to basement membranes in extra-renal tissues. One kidney of a Gpx3 -/-mouse was replaced by a kidney from a Gpx3 +/+ mouse. Figure 7 shows the effect of transplanting Gpx3 +/+ kidneys on the presence of Gpx3 in the native
Gpx3
-/-kidneys. In each case, Gpx3 synthesized in the Gpx3 +/+ kidney appeared in the native Gpx3 -/-kidney. This indicates that the transplanted Gpx3 +/+ kidneys were synthesizing and secreting Gpx3 even though they did not significantly increase plasma glutathione peroxidase activity. Figure 3C shows that the transplant resulted in Gpx3 appearing in the basement membrane of the jejunum in the same pattern seen in Gpx3 +/+ mice (Fig 3A) . Similar results were obtained with lung type II pneumocytes (Fig 4B) , efferent duct (Fig 5C) , and other tissues, including the remaining Gpx3 -/-kidney ( kidneys. This allows the conclusion that a specific binding site for Gpx3 is present only on certain basement membranes (see Table 1 ) and that Gpx3 synthesized by the kidney and released into the blood has access to that site.
Source of Gpx3 in the lumen of the epididymis
Transplantation of a Gpx3 +/+ kidney did not cause Gpx3 to appear in the cells of the epididymis or in its lumen (Fig 6D) . Because the epididymis contains a relatively high concentration of Gpx3 mRNA (Fig 1) and Gpx3 is present in epididymal epithelial cells at the expected position of the Golgi apparatus, these results strongly suggest that Gpx3 is synthesized in the epididymal epithelial cells and secreted apically into the lumen.
Binding of Gpx3 in kidney and small intestine at varying plasma levels
The transplant experiment showed that Gpx3 produced by kidney can traverse the blood and bind to basement membranes in other tissues. We carried out experiments to characterize the Gpx3 binding in different locations.
Selenium concentration was measured in kidney, small intestine, and liver of Gpx3
and Gpx3 -/-mice fed a diet supplemented with 0.25 mg selenium per kg for 4 weeks beginning at weaning to assess the amount of Gpx3 present in them. Table 2 shows that deletion of Gpx3 lowered selenium concentration by 280 ng/g in kidney and by 40 ng/g in small intestine. The apparent decrease in liver was not statistically significant. These results suggest that a greater amount of Gpx3 is present in kidney than in intestine.
Using quantitative western blotting, we assessed the amount of Gpx3 in kidney, plasma, and small intestine as a function of selenium nutritional status to determine whether Gpx3 concentrations in these compartments correlate with one another. This experiment was performed because kidney transplant had shown that small intestine basement membranes bound Gpx3 (Fig 3C) even when plasma glutathione peroxidase activity was not significantly increased (see above), suggesting that binding affinity in the intestine was relatively high. The results presented in figure 8 show that selenium nutritional status affected plasma and kidney Gpx3 protein concentrations similarly. The signal from intestine was too small to be quantified in this experiment and thus we could not compare binding there with binding in the kidney. These results and those in Table 2 indicate that the concentration of Gpx3 in the small intestine was less than that in the kidney. They further indicate that plasma Gpx3 and kidney Gpx3 concentrations vary in a similar manner under these conditions.
Discussion
The results presented here demonstrate that Gpx3 binds to specific basement membranes-not only in the kidney as previously described but also in the gastrointestinal tract, the lung, and the male reproductive tract. They also show that Gpx3 produced by the kidney can travel through the blood and bind to those same basement membranes, indicating that binding sites for Gpx3 are present on them. In addition, our results show that Gpx3 produced in the kidney does not have access to the epididymal lumen and strongly suggest that Gpx3 present there is secreted by the epididymal epithelium. These findings demonstrate that Gpx3 is distributed within compartments.
Although Gpx3 had been previously observed to be present in the basal extracellular space of kidney tubules (22), we recently showed that it binds to a specific population of kidney basement membranes (16) . The present report extends that observation to other tissues and shows that this binding is cell specific. For example, the basement membrane under type II pneumocytes binds Gpx3 while the basement membrane continuous with it, but under type I pneumocytes, does not bind the enzyme (Fig 4A) . The same pattern of binding was observed for Gpx3 produced by a transplanted kidney (Fig 4B) , eliminating the possibility that the type II pneumocyte had secreted the Gpx3 attached to its basement membrane. This indicates that the overlying cell produces Gpx3 binding sites on the basement membrane. Thus, it can be predicted that these cells, and perhaps other cells, can be induced to modify their basement membranes so that they bind Gpx3 in greater or lesser quantities, according to their need for the enzyme.
The nature of the Gpx3 binding sites on the basement membranes remains unknown.
Possibilities include that the overlying cell secretes a unique Gpx3-binding protein that attaches to the basement membrane or that the cell modifies some of the usual constituents of the basement membrane to form the binding site. It is also possible that more than one type of binding site exists, each type perhaps having a different function.
Additional study will be needed to characterize the binding sites and to determine their affinity for Gpx3.
Recognition that Gpx3 binds to basement membranes provides a rationale for its function in vivo as a glutathione peroxidase. Enzymatic function of Gpx3 in plasma has been questioned because GSH, its reducing substrate, is present in plasma at concentrations unfavorable to the kinetics of the enzyme (4). Many cells, if not all of them, secrete GSH and thus create a zone of relatively high GSH concentration in proximity to the secreting plasma membrane (6). As a consequence, Gpx3 attached to the basement membrane will be exposed to a higher GSH concentration than Gpx3 in plasma. Moreover, bound Gpx3 will presumably be in equilibrium with unbound enzyme in the adjacent extracellular space, increasing the amount of unbound Gpx3 at this location. Thus, we propose that basement membrane binding of Gpx3 increases glutathione peroxidase activity at the basal extracellular aspect of the overlying epithelial Kidney PCT cells have long been known to produce most of the Gpx3 in plasma (2).
Based on the decrease in tissue selenium content when Gpx3 was deleted (Table 2) , it appears that a greater concentration of the enzyme is present in kidney than in intestine.
The experiment depicted in Figure 8 was designed to determine kidney and intestinal Gpx3 concentrations at varying plasma Gpx3 levels with the aim of comparing binding affinities for Gpx3 in these tissues. We were motivated by the observation that plasma levels of Gpx3 fall sharply in patients with renal failure and hoped to learn whether decreased plasma Gpx3 would lead to a decrease in its concentration in the small intestine. The experiment failed in that objective because we could not quantify intestinal Gpx3. However, kidney and plasma Gpx3 showed good correlation over the range of selenium intakes studied (Fig 8) . This observation is consistent with the kidney basement membranes serving as a reservoir for plasma Gpx3. It seems possible that renal basement membrane-bound Gpx3, a pool of Gpx3 larger than the plasma Gpx3 pool (16), buffers plasma Gpx3 and thereby supports the supply of the enzyme to peripheral tissues via the plasma. The transplant experiments show that remote tissues bind Gpx3 produced by the kidney (Fig 3) even when plasma levels of the enzyme are quite low (see Results). It will thus be important for the understanding of Gpx3 physiology to determine the nature of the binding sites in different tissues and their relative affinities for Gpx3.
Our results demonstrate that Gpx3 is present in the lumen of the epididymis (Fig 6) and that the epithelial cells in that organ contain Gpx3 at the location of the Golgi apparatus ( Figs 6A and 6C) . Thus, we infer that these cells secrete Gpx3 apically into the lumen. Earlier work using antibody detection suggested that Gpx3 was present in the cytosol of epididymal epithelial cells and did not detect Gpx3 in fluid obtained by perfusion of the epididymis (19) . Our demonstration that Gpx3 staining is present in the epididymal lumen of Gpx3 +/+ mice but not of Gpx3 -/-mice demonstrates the specificity of our antibody preparation and supports our contention that Gpx3 is present in the lumen where spermatozoa are stored.
Our results have identified two Gpx3 compartments in the organism that are separate from one another. One is the combined blood-interstitial space that is supplied with
Gpx3 by the kidney and the other is the epididymal lumen, presumably supplied by the epididymal epithelial cells. Kidney and epididymis both contain high concentrations of Gpx3 mRNA (Fig 1) . Other tissues contain Gpx3 mRNA, albeit at lower concentrations (Fig 1) , so other compartments are likely to exist. In particular, lung appears to secrete
Gpx3 into the airways (1). Epithelial cells in the mammary gland, the thyroid gland, and the yolk sac secrete it as well (3, 11, 18). More work will be needed to determine the disposition and function of the Gpx3 expressed by each tissue.
Several pathologic conditions increase Gpx3 in the compartment fed by the kidney.
The inflammatory colitis caused in mice by dextran sodium sulfate administration raises the concentration of Gpx3 mRNA in kidney and Gpx3 in plasma (21) . Exposure of mice to 100% oxygen for 72 hours raises plasma and lung Gpx3 concentrations (10). Patients with cirrhosis have increased plasma glutathione peroxidase activity that is presumably due to Gpx3 (5). Oxidative stress occurs in all these conditions and may be the cause of the Gpx3 increase.
Plasma Gpx3 falls in kidney failure (2). Thus, it will be important to determine the relationship of the plasma Gpx3 level with Gpx3 function in tissues where the enzyme is bound to basement membranes. Inadequate Gpx3 may play a role in how renal failure 
